Understanding end-of-life decisions in young adults with advanced cancer
Part of Cancer clinical trials.
This study talks with young adults aged 15-39 with advanced, spreading cancer to understand how they and their doctors make decisions about end-of-life care. The goal is to improve support for patients facing these tough choices.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older now
- You must have a solid tumor (not a blood cancer like leukemia or lymphoma)
- You must have been diagnosed with cancer between ages 15 and 39
- Your cancer must have spread to other parts of your body (metastasis)
- The first standard treatment you got after the cancer spread must have stopped working
- You must be able to talk in an interview for about 30 minutes without too much difficulty
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how much young people with cancer (ages 15–29) want to be involved in making decisions about their care. It's for those currently on treatment, at end of life, or who finished treatment up to a year ago.
This study tests an educational tool to help young adults with advanced solid tumors or high-grade brain tumors think about and discuss their future healthcare wishes early. It may help you feel more prepared and in control of your care.
This study looks at ways to help people with advanced cancer or aggressive lymphoma make better treatment decisions with their doctors. If you qualify, you'll be asked to read a short story about a patient in a similar situation and answer questions about your thoughts on care options.
This study tests an educational program to help patients with advanced cancer talk about their goals of care. The goal is to make sure your wishes are known and respected by your care team.
This study tests a new way to help you and your doctor choose the best cancer treatment together. If you are 18 or older, in a participating hospital's oncology program, and have not yet made a treatment decision, this trial may be a good fit.
This study is testing a tool called TA-DA to help patients with advanced cancer and their caregivers make decisions about further treatment after at least two prior therapies. It aims to improve shared decision-making.
Hear when a new End of Life Decision Making trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.